Maria J H Boumans

Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis

Tamara H. Ramwadhdoebé, Lisa G. M. van Baarsen, Maria J H Boumans et al. · Lara D. Veeken · 2018 · 148 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Brief Report: A phase IIa, randomized, double‐blind, placebo‐controlled trial of apilimod mesylate, an interleukin‐12/interleukin‐23 inhibitor, in patients with rheumatoid arthritis

Sarah Krausz, Maria J H Boumans, Daniëlle M. Gerlag et al. · Arthritis & Rheumatism · 2011 · 84 citations

Medicine, Pharmacology, Pharmacotherapy +16

Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis

Maria J H Boumans, Rogier M. Thurlings, Lorraine Yeo et al. · Annals of the Rheumatic Diseases · 2011 · 74 citations

Medicine, Immunology, Pathology +17

Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire

Sabrina Pollastro, Paul L. Klarenbeek, Marieke E. Doorenspleet et al. · Annals of the Rheumatic Diseases · 2019 · 60 citations · Full text

Life Sciences, Clinical Sciences, Immunology +17

Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study

Maria J H Boumans, J. G. A. Houbiers, Patrick Verschueren et al. · Annals of the Rheumatic Diseases · 2011 · 54 citations · Full text

Medicine, Immunology, Pharmacology +17